ask="16.00"
ask_size="100"
average_daily_volume="36850"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="+0.33"
change_from_200_day_moving_average="-3.98"
change_from_50_day_moving_average="-3.93"
change_from_52_week_high="-11.24"
change_From_52_week_low="5.10"
change_in_percent="+2.23%"
close="15.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6895000"
high="15.22"
high_52_weeks="26.36"
last_trade_date="2/15/2017"
last_trade_price="15.12"
last_trade_size="366"
last_trade_time="4:00pm"
low="14.26"
low_52_weeks="10.02"
market_capitalization="252.72M"
moving_average_200_day="19.10"
moving_average_50_day="19.05"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="14.69"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.83%"
percent_change_from_50_day_moving_average="-20.61%"
percent_change_from_52_week_high="-42.64%"
percent_change_from_52_week_low="+50.90%"
previous_close="14.79"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.54"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="7.43"
stock_exchange="NGM"
symbol="PTGX"
volume="38791"
weeks_range_52="10.02 - 26.36"
